← SynDRA
LB-100
SynDRA canonical compound SYN0039474 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PPP5C |
|---|
| Mechanism of action | protein phosphatase inhibitor |
|---|
| Indication | depression |
|---|
| Disease area | Neurology |
|---|
All known targets
Mechanisms of action (all sources)
- PPP2CA INHIBITOR
- Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform inhibitor
- PPP2CB INHIBITOR
- Serine/threonine protein phosphatase 2A, catalytic subunit, beta isoform inhibitor
- PPP5C INHIBITOR
- Serine/threonine-protein phosphatase 5 inhibitor
- protein phosphatase inhibitor
Cross-references
Synonyms
- LB 100
- EMPM
- 0C1JUU9S0L
- RefChem:152591
- DTXCID501563640
- LB100
- MFCD28167839
- endothall 4-methylpiperazine monoamide
- UNII-0C1JUU9S0L
- orb1302850
- SCHEMBL9880148
- GTPL11105
- HQC03253
- AKOS027338657
- AC-37584
- DA-74917
- TS-09026
- T4449
Look up LB-100 in the interactive SynDRA portal →